Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
PBH 
Prestige Brand Holdings Inc (PBH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/08/2025: PBH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $78
1 Year Target Price $78
| 3 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/08/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.97B USD | Price to earnings Ratio 14.93 | 1Y Target Price 78 |
Price to earnings Ratio 14.93 | 1Y Target Price 78 | ||
Volume (30-day avg) 7 | Beta 0.39 | 52 Weeks Range 57.25 - 90.04 | Updated Date 12/8/2025 |
52 Weeks Range 57.25 - 90.04 | Updated Date 12/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 18.09% | Operating Margin (TTM) 29.07% |
Management Effectiveness
Return on Assets (TTM) 6.37% | Return on Equity (TTM) 11.29% |
Valuation
Trailing PE 14.93 | Forward PE 13.85 | Enterprise Value 3846387488 | Price to Sales(TTM) 2.67 |
Enterprise Value 3846387488 | Price to Sales(TTM) 2.67 | ||
Enterprise Value to Revenue 3.46 | Enterprise Value to EBITDA 10.78 | Shares Outstanding 48084010 | Shares Floating 47513253 |
Shares Outstanding 48084010 | Shares Floating 47513253 | ||
Percent Insiders 1.28 | Percent Institutions 109.34 |
Upturn AI SWOT
Prestige Brand Holdings Inc
Company Overview
History and Background
Prestige Brand Holdings Inc. was founded in 1996 as an operating company of Cadbury Schweppes plc. It became an independent, publicly traded company in 2007 through a spin-off from Cadbury. The company has a history of acquiring and integrating well-known consumer healthcare and household cleaning brands.
Core Business Areas
- Consumer Healthcare: This segment includes a portfolio of over-the-counter (OTC) healthcare products. Brands in this segment focus on treating common ailments, pain relief, and personal care needs. Key categories include cough, cold, flu, pain management, allergy, and digestive health.
- Home and Garden: This segment encompasses a range of household cleaning products and lawn and garden care items. Brands focus on pest control, air care, and surface cleaning solutions for consumers and professionals.
Leadership and Structure
Prestige Brand Holdings Inc. is led by a management team with extensive experience in the consumer packaged goods industry. The company operates through a matrix structure, overseeing its various brands and product lines across its core business segments. Specific details on the current leadership team and their roles are typically available in their annual reports and investor relations sections.
Top Products and Market Share
Key Offerings
- Delsym: A leading cough suppressant brand known for its extended-release formula. Competitors include Robitussin (Pfizer), Mucinex (Reckitt Benckiser), and store-brand equivalents. Specific market share data for individual brands is often proprietary, but Delsym is a significant player in the cough and cold market.
- kesehatan: A prominent brand in the digestive health category, offering remedies for heartburn and indigestion. Key competitors include Tums (GSK plc), Rolaids (Johnson & Johnson), and various store brands.
- Chloraseptic: A well-known brand of sore throat relief products, including lozenges and sprays. Competitors include Cepacol (Mundipharma), Ricola (Ricola AG), and store brands.
- Ambi: A skincare brand focused on treating hyperpigmentation and dark spots. Competitors include Neutrogena (Johnson & Johnson), Olay (Procter & Gamble), and other specialized skincare brands.
- Raid: A leading brand in household pest control, offering insecticides and repellents. Major competitors include Hot Shot (United Industries), Terro (Woodstream Corporation), and various store brands.
- Black Flag: Another established brand in the pest control market, offering a range of insect control products. Competitors are largely the same as Raid.
Market Dynamics
Industry Overview
Prestige Brand Holdings Inc. operates within the consumer healthcare and household cleaning industries, which are characterized by strong brand loyalty, ongoing innovation, and sensitivity to economic conditions. The consumer healthcare market is driven by an aging population, increased health consciousness, and a preference for self-care solutions. The household cleaning market is influenced by consumer demand for convenience, efficacy, and increasingly, eco-friendly products.
Positioning
Prestige Brand Holdings Inc. is positioned as a leading provider of branded over-the-counter healthcare and household cleaning products. Its competitive advantage lies in its portfolio of strong, established brands with significant consumer awareness and loyalty, a well-developed distribution network, and a history of successful brand extensions and acquisitions.
Total Addressable Market (TAM)
The global over-the-counter (OTC) healthcare market is substantial, estimated to be in the hundreds of billions of dollars and growing. Similarly, the global household cleaning market is also a multi-billion dollar industry. Prestige Brand Holdings Inc. is a significant player within these markets, particularly in North America, but operates within a highly fragmented landscape with both large multinational corporations and smaller niche players.
Upturn SWOT Analysis
Strengths
- Strong portfolio of well-established and recognized brands.
- Significant brand loyalty and consumer trust.
- Extensive distribution network across North America.
- Proven track record of successful acquisitions and integrations.
- Experienced management team with industry expertise.
Weaknesses
- Dependence on a limited number of key brands.
- Vulnerability to increased competition from private label brands.
- Potential for market share erosion due to changing consumer preferences.
- Reliance on retail partners for product placement and sales.
Opportunities
- Expansion into international markets.
- Development and launch of new, innovative products.
- Strategic acquisitions to broaden product portfolio and market reach.
- Leveraging e-commerce channels for direct-to-consumer sales.
- Growing consumer demand for natural and organic products in both segments.
Threats
- Intensifying competition from larger CPG companies and private labels.
- Regulatory changes affecting the OTC healthcare market.
- Fluctuations in raw material costs and supply chain disruptions.
- Economic downturns impacting consumer discretionary spending.
- Shifting consumer trends towards preventive healthcare and wellness.
Competitors and Market Share
Key Competitors
- Reckitt Benckiser Group plc (RBG - LSE)
- Procter & Gamble Company (PG)
- Johnson & Johnson (JNJ)
- GlaxoSmithKline plc (GSK - LSE)
- Pfizer Inc. (PFE)
- Church & Dwight Co., Inc. (CHD)
Competitive Landscape
Prestige Brand Holdings Inc. faces a highly competitive landscape with large, diversified multinational corporations and numerous smaller, specialized companies. Its advantages lie in its focused portfolio of trusted brands and strong retail relationships. However, it must continuously innovate and adapt to compete with the vast R&D budgets and global reach of its larger rivals. Its agility in executing smaller, targeted acquisitions can also be a competitive advantage against slower-moving giants.
Major Acquisitions
Alva-Amco
- Year: 2017
- Acquisition Price (USD millions): 146
- Strategic Rationale: Acquired to expand Prestige Brands' consumer healthcare portfolio, particularly in the vitamins and supplements category, and to strengthen its presence in the pain relief and topical analgesics market.
Lapeyrie SAS
- Year: 2019
- Acquisition Price (USD millions): 36
- Strategic Rationale: Acquired to enhance Prestige Brands' European presence and expand its portfolio in the cough, cold, and flu remedies segment within the European market.
Fleet Laboratories
- Year: 2021
- Acquisition Price (USD millions): 350
- Strategic Rationale: Acquired to bolster Prestige Brands' consumer healthcare business, adding key brands in the digestive health and pain management categories, and expanding its over-the-counter offerings.
Growth Trajectory and Initiatives
Historical Growth: Prestige Brand Holdings Inc. has historically pursued growth through a combination of organic brand development and strategic acquisitions. The company has shown a capacity to successfully integrate acquired brands into its portfolio and leverage them for growth. Revenue growth has been a consistent theme, though the pace can vary based on acquisition activity and market conditions.
Future Projections: Future growth projections for Prestige Brand Holdings Inc. are typically influenced by analyst estimates based on industry trends, the company's strategic initiatives, and its pipeline of potential acquisitions. Analysts often forecast revenue growth, EPS increases, and potential margin improvements. These projections are subject to change based on evolving market dynamics and company performance.
Recent Initiatives: Recent initiatives may include efforts to strengthen core brands through marketing and innovation, expanding into new product categories, optimizing supply chain operations, and exploring opportunities in emerging markets. The company also actively evaluates potential acquisitions that align with its strategic objectives and financial criteria.
Summary
Prestige Brand Holdings Inc. is a well-established player in the consumer healthcare and household cleaning sectors, distinguished by its portfolio of trusted brands and strong market presence in North America. The company has a proven strategy of growth through strategic acquisitions and organic brand development. While facing intense competition from larger rivals and the threat of private labels, its focus on brand loyalty and potential for international expansion offers avenues for continued success. Vigilance regarding evolving consumer preferences and market dynamics is crucial for maintaining its competitive edge.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations (Annual Reports, SEC Filings)
- Financial News Outlets (e.g., Wall Street Journal, Bloomberg)
- Market Research Reports
- Industry Analysis Websites
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Market share data is estimated and may vary. Financial data should be verified with official company filings. Investing in the stock market involves risks, and investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Prestige Brand Holdings Inc
Exchange NYSE | Headquaters Tarrytown, NY, United States | ||
IPO Launch date 2005-02-10 | Chairman, President & CEO Mr. Ronald M. Lombardi CPA | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 600 | Website https://www.prestigebrands.com |
Full time employees 600 | Website https://www.prestigebrands.com | ||
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.